Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Seagen Inc.
Eli Lilly and Company
Pfizer
Pfizer
Accent Therapeutics
Novartis
Novartis
Chongqing Precision Biotech Co., Ltd
Elicio Therapeutics
Medicine Invention Design, Inc
GILongevity
Amal Therapeutics
Hutchmed
UTC Therapeutics Inc.
Corvus Pharmaceuticals, Inc.
Chongqing Precision Biotech Co., Ltd
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Novartis
MacroGenics
Targovax ASA
Adlai Nortye Biopharma Co., Ltd.
Gilead Sciences
Array BioPharma
TG Therapeutics, Inc.
Novartis
Novadaq Technologies ULC, now a part of Stryker
SillaJen, Inc.
Eli Lilly and Company
Amgen
Light Sciences LLC